Clinical Trial Update: A Study to Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo [Phase 1]

View source ↗

Summary

Phase 1 trial update on two Ebola vaccines, ChAd3-EBO Z and MVA-BN Filo; the Oxford study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• ChAd3-EBO-Z
• MVA-BN-Filo

Snippet

Sponsor: University of Oxford | Conditions: Ebola, Ebola Zaire | Phase 1 | Status: COMPLETED